SUBSCRIPTION AGREEMENTSubscription Agreement • October 14th, 2005 • Ziopharm Oncology Inc • Services-business services, nec • Delaware
SUBSCRIPTION AGREEMENT (this “Agreement”) made as of the last date set forth on the signature page hereof between Ziopharm, Inc. (the “Company”), and the undersigned (the “Subscriber”).
EMPLOYMENT AGREEMENTEmployment Agreement • October 14th, 2005 • Ziopharm Oncology Inc • Services-business services, nec • New York
AGREEMENT (the “Agreement”), dated as of January 15, 2004, by and between ZIOPHARM, INC., a Delaware corporation with principal executive offices at 787 Seventh Avenue, 48th Floor, New York, NY 10019 (the “Company”), and ROBERT PETER GALE, M.D., Ph.D., residing at 11693 San Vicente Blvd., Suite 335, Los Angeles, CA 90049 (the “Employee”).
EMPLOYMENT AGREEMENTAgreement • October 14th, 2005 • Ziopharm Oncology Inc • Services-business services, nec • New York
AGREEMENT (the “Agreement”), dated as of January 8, 2004, by and between ZYLOGEN, INC., a Delaware corporation with principal executive offices at 787 Seventh Avenue, 48th Floor, New York, NY 10019 (the “Company”), and DR. JONATHAN LEWIS, residing at 1522 Fairfield Beach Road, Fairfield, CT 06824 (the “Executive”).
ContractZiopharm Oncology Inc • October 14th, 2005 • Services-business services, nec • New York
THIS WARRANT AND THE SECURITIES ISSUABLE UPON EXERCISE HEREOF HAVE BEEN ACQUIRED FOR INVESTMENT AND HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE “ACT”), OR ANY STATE SECURITIES LAW. THIS WARRANT AND SUCH SECURITIES MAY NOT BE OFFERED, SOLD OR OTHERWISE PLEDGED, TRANSFERRED OR HYPOTHECATED IN THE ABSENCE OF SUCH REGISTRATION OR DELIVERY OF AN OPINION OF COUNSEL IN FORM AND SUBSTANCE REASONABLY SATISFACTORY TO THE COMPANY THAT SUCH OFFER, SALE OR TRANSFER, PLEDGE OR HYPOTHECATION IS IN COMPLIANCE WITH THE ACT OR UNLESS SOLD IN FULL COMPLIANCE WITH RULE 144 UNDER THE ACT.
PATENT AND TECHNOLOGY LICENSE AGREEMENTStock Purchase Agreement • October 14th, 2005 • Ziopharm Oncology Inc • Services-business services, nec • New York
This fifty-two (52) page AGREEMENT ("AGREEMENT") is made on this 24th day of August, 2004, by and between THE BOARD OF REGENTS ("BOARD") of THE UNIVERSITY OF TEXAS SYSTEM ("SYSTEM"), an agency of the State of Texas, whose address is 201 West 7th Street, Austin, Texas 78701, on behalf of THE UNIVERSITY OF TEXAS M. D. ANDERSON CANCER CENTER ("UTMDACC"), a component institution of SYSTEM, The Texas A&M University System (“A&M”), an agency of the State of Texas located at College Station, Texas 77843, and Ziopharm Inc., a Delaware corporation having a principal place of business located at 787 Seventh Avenue, 48th Floor, New York, NY 10019 ("LICENSEE").
LICENSE AGREEMENTLicense Agreement • October 14th, 2005 • Ziopharm Oncology Inc • Services-business services, nec • Connecticut
This License Agreement (hereinafter referred to as this "Agreement"), effective as of October 15, 2004 2004, (the “Effective Date”), is entered into by and between DEKK-TEK, Inc., having an address at 4200 Canal Street, Suite A, New Orleans, LA, 70119 (the “Licensor”) and ZIOPHARM, Inc., having an address at 300 George St., Suite 5, New Haven, CT 06511 (the "Company").
